bicalutamide has been researched along with Adenocarcinoma in 116 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (7.76) | 18.2507 |
| 2000's | 63 (54.31) | 29.6817 |
| 2010's | 39 (33.62) | 24.3611 |
| 2020's | 5 (4.31) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuoka, K; Hayashi, T; Inoue, S; Kadonishi, Y; Kajiwara, M; Kobayashi, K; Matsubara, A; Mita, K; Nagamatsu, H; Shigeta, M; Tacho, T; Teishima, J | 1 |
| Aebersold, DM; Albrecht, C; Böhmer, D; Flentje, M; Ganswindt, U; Ghadjar, P; Höcht, S; Hölscher, T; Müller, AC; Niehoff, P; Pinkawa, M; Sedlmayer, F; Wiegel, T; Zips, D | 1 |
| Asioli, S; Fabbri, VP; Palandri, G | 1 |
| Fujita, K; Imamura, R; Kawashima, A; Kiuchi, H; Koh, Y; Miyagawa, Y; Nagahara, A; Nonomura, N; Uemura, M; Ujike, T | 1 |
| Deng, G; Fang, Q; Huang, S; Ji, H; Jia, M; Li, W; Liao, Q; Meng, M | 1 |
| Badiozamani, KR; Beyer, DC; Harris, J; Horwitz, EM; Hurwitz, MD; Lawton, CAF; Michalski, JM; Roof, K; Sandler, HM; Sartor, O; Shayegan, B; Sperduto, PW; Xiao, Y; Zhang, Q | 1 |
| Ferlicot, S | 1 |
| Cruz-Conde de Boom, R; de Lara-Simón, IM; Flores-Terry, MÁ; García-Arpa, M | 1 |
| Bertolín-Colilla, M; Deza, G; Lobato-Berezo, A; March-Rodríguez, A; Pujol, RM | 1 |
| Akaev, I; Brennan, PA; Chhikara, R; Dabab, N; Fonseca, F; Gomez, RS; Rahimi, S; Rigby, E; Yeoh, CC | 1 |
| Angermeier, KW; Bryk, DJ; Klein, EA | 1 |
| Dalgleish, AG; Di Palma, S; Fusi, A; Nathan, K; Patel, N; Powell, B | 1 |
| Cohen, P; Corman, JM; Dalkin, BL; Dean, JP; Ellis, WJ; Haugk, K; Lin, DW; Montgomery, B; Mostaghel, E; Nelson, PS; Plymate, SR; Sprenger, CC; Wan, J | 1 |
| Corn, PG; DePetrillo, TA; Heath, E; Kuban, D; Maier, J; Mathew, P; Meyn, R; Song, DY | 1 |
| Amato, R; Gonzales, P; Stepankiw, M | 1 |
| Burnett, AL; Goetz, T | 1 |
| Anda, T; Honda, M; Ishihara, T; Kamei, T | 1 |
| Chaudhary, U; Golshayan, AR; Keane, TE; Kraft, AS; Marshall, DT; Ramey, S | 1 |
| Bossi, P; Civelli, E; Cortelazzi, B; Imbimbo, M; Licitra, L; Locati, LD; Perrone, F; Pilotti, S; Potepan, P; Quattrone, P; Rinaldi, G | 1 |
| Daverede, L; Harnden, P; Jagdev, SP; Paul, A; Ralph, C; Trainor, S; Trigonis, I; Vasudev, NS; Weston, M | 1 |
| Choufani, E; Manov, A; Subramaniam, S | 1 |
| Esa, A; Hara, I; Iki, M; Imanishi, M; Kajikawa, H; Komura, T; Matsuyama, H; Nagao, K; Nishioka, T; Nozawa, M; Ogawa, T; Uejima, S; Uekado, Y; Uemura, H | 1 |
| Alvarez, A; Boladeras, A; Cabeza Rodríguez, MA; Calvo, FA; Casas, F; de Vidales, CM; Gonzalez San Segundo, C; Guerrero, A; Macias, V; Maldonado, X; Pedro Olive, A; Perez de la Haza, A; Vazquez de la Torre, ML; Villà, S; Zapatero, A | 1 |
| Doreswamy, K; Karthikeyan, VS; Nagabhushana, M; Shankaranand, B | 1 |
| Karihtala, P; Rissanen, T; Tuominen, H | 1 |
| Chertcoff, JF; Dezanzo, P; Di Tullio, F; Ernst, G; Molina Mancero, G; Picón, X; Salvado, A | 1 |
| Chesa, N; Déniz, F; Domínguez, C; Lara, PC; Lloret, M; Naranjo, A; Ojeda, S | 1 |
| Das, K; Farcon, E; Gorokhovsky, R; Rapkiewicz, A | 1 |
| Belanger, A; Chertin, B; Farkas, A; Fridmans, A; Hartman, H; Labrie, F; Spitz, IM | 1 |
| Alavian, MR; Fitzgerald, TJ; Goel, HL; Languino, LR; Wang, T | 1 |
| Chen, H; deVere White, RW; Gandour-Edwards, R; Shi, XB; Xue, L; Zou, JX | 1 |
| Chadha, MK; Lau, YK; Litwin, A; Trump, DL | 1 |
| Chaudhary, U; Turner, J | 1 |
| Baten, A; Blokx, WA; Hoogendam, A; Molenaar, JP | 1 |
| Arslan, G; Efe, E; Onal, C; Topkan, E; Yavuz, A; Yavuz, M | 1 |
| Desiniotis, A; Eder, IE; Klocker, H; Schäfer, G | 1 |
| Favaudon, V; Giocanti, N; Hennequin, C; Quéro, L | 1 |
| Arcangeli, G; Arcangeli, S; Fowler, J; Gomellini, S; Landoni, V; Marzi, S; Petrongari, MG; Saracino, B; Sentinelli, S; Strigari, L | 1 |
| Njiaju, UO; Truica, CI | 1 |
| Coleman, CN; Gulley, J; Kamrava, M; Kaushal, A; Madan, RA; Tsang, KY | 1 |
| Fradet, Y; Lacombe, L; Lodde, M | 1 |
| Bassi, P; Brescia, A; Gardi, M; Gulino, G; Pinto, F; Sacco, E; Volpe, A | 1 |
| Arribas, L; Carrascosa, M; Casanova, J; Crispín, V; Gimeno, J; Guinot, JL; Ricós, JV; Santos, M; Soler, P; Tortajada, MI | 1 |
| Heintz, J; Kahn, B; Kramer, A | 1 |
| Kakehi, Y; Kato, T; Kazuki, N; Kushida, Y; Kuwata, Y; Matsuoka, Y; Taoka, T; Yamamoto, N | 1 |
| Capodice, JL; Katz, AE; Xie, B; Yan, J | 1 |
| Chuu, CP; Fukuchi, J; Hiipakka, RA; Huo, C; Kokontis, JM; Liao, S; Lin, CY; Lin, HP; Su, LC | 1 |
| Cheng, H; Fazli, L; Gleave, ME; Lamoureux, F; Rennie, PS; Thomas, C; Wafa, LA | 1 |
| López, MA; Morote, J; Placer, J; Planas, J; Raventós, C; Ropero, J; Salvador, C | 1 |
| Erkkilä, T; Jalava, S; Kaipia, A; Kujala, P; Lähdesmäki, H; Lehmusvaara, S; Seppälä, J; Tammela, TL; Urbanucci, A; Visakorpi, T | 1 |
| Bubley, GJ; Buckle, G; Courtney, KD; Elfiky, A; Hayes, JH; Kantoff, PW; Nakabayashi, M; Oh, WK; Sims, DM; Taplin, ME; Weckstein, D; Werner, L | 1 |
| Date, S; Hirayama, K; Mukaisho, K; Nagashima, T; Niiro, M; Okihara, K | 1 |
| Riedl, CR; Stangelberger, A; Susani, M | 1 |
| Beer, TM; Drake, CG; Graff, JN | 1 |
| Bahnson, R; Bissonette, EA; Miller, NL; Theodorescu, D; Wilson, J | 1 |
| Duncan, WE; Harding, P; Howard, RS; McLeod, DG; Preston, DM; Torréns, JI | 1 |
| Bjeldanes, LF; Firestone, GL; Le, HT; Schaldach, CM | 1 |
| Fukui, I; Maezawa, T; Nakaishi, M; Sakura, M; Takimoto, K; Tsukamoto, T; Yonese, J | 1 |
| Febbo, P; Kantoff, PW; Kaplan, ID; Kaufman, DS; Manola, J; Oh, WK; Prisby, J | 1 |
| Bossi, P; Cantù, G; Licitra, L; Locati, LD; Marchianò, AV; Quattrone, P | 1 |
| Abdalla, I; Basu, A; Connell, PP; Jani, AB; Krauz, L; Vijayakumar, S | 1 |
| Burnstein, KL; Hayakawa, K; Kizu, R; Klinge, CM; Mizokami, A; Okamura, K; Toriba, A | 1 |
| Campo, B; Colombo, P; Giunta, P; Mazzucchelli, R; Montironi, R; Parente, M; Patriarca, C; Petrella, D; Zucchini, N | 1 |
| Hellerstedt, B | 1 |
| Di Silverio, F; Sciarra, A | 1 |
| Kijima, T; Okuno, T; Sakai, Y; Wakui, M | 1 |
| Febbo, PG; George, DJ; Kantoff, PW; Kaplan, ID; Kaufman, DS; Leibowitz, SB; Manola, J; Oh, WK; Regan, MM; Smith, MR; Tay, MH | 1 |
| Gandhok, N; Sartor, O | 1 |
| Baltogiannis, D; Charalabopoulos, K; Giannakopoulos, X; Sofikitis, N | 1 |
| Levinson, A; Lowe, FC; Nagler, EA | 1 |
| Chianakwalam, CI; Griffiths, NJ; McCahy, P | 1 |
| Cangh, PV; Colombeau, P; Garside, L; Haustermans, K; Keuppens, F; Morris, T; Tyrrell, CJ; Van Poppel, H | 1 |
| Nakamura, M; Sakai, N; Shioi, K; Yoshida, M | 1 |
| Kirby, R | 2 |
| Beer, TM; Garzotto, M; Janoff, DM; Mongoue-Tchokote, S; Mori, M; Peters, L; Peterson, C; Wersinger, EM | 1 |
| Hirsch, IB; Paniagua, MA | 1 |
| Abe, H; Katsuoka, Y; Nishida, T; Segawa, N | 1 |
| Cardi, A; Dattilo, C; Di Monaco, F; Di Silverio, F; Mariotti, G; Sciarra, A | 1 |
| Daskivich, TJ; Oh, WK | 1 |
| Freschi, M; Losa, A; Mazzucchelli, R; Montironi, R; Montorsi, F; Nava, L; Pappagallo, G; Rigatti, P; Scarpa, RM; Scattoni, V; Terrone, C | 1 |
| Akdogan, B; Akyol, F; Karabulut, E; Onal, C; Ozen, H; Ozyigit, G; Selek, U | 1 |
| Engstrom, C | 1 |
| Higashihara, E; Kinjo, M; Nutahara, K; Okegawa, T | 1 |
| Chang, CY; Elbi, C; Hager, GL; Hendarwanto, A; Klokk, TI; Kurys, P; Nagaich, AK; Saatcioglu, F; Slagsvold, T | 1 |
| Hasegawa, Y; Masue, N | 1 |
| Arima, K; Onishi, T; Soga, N; Sugimura, Y | 1 |
| Bastian, PJ; Biermann, K; Bollmann, D; Ellinger, J; Müller, SC; Schmidt, ME; Textor, J; Zhou, H | 1 |
| Bidaisee, LA; Bryskine, I; Gupta, RS; Lin, H; Lu, JP; Pinthus, JH; Singh, G | 1 |
| Dewilde, S; Kleinman, L; Lloyd, A; Penson, D | 1 |
| Slovin, SF | 1 |
| Nemoto, K; Tomita, Y | 1 |
| Jennrich, R; Johnson, H; Lam, R; Scholz, M; Strum, S; Trilling, T | 1 |
| Brehmer, B; Jakse, G; Makris, A; Wellmann, A | 1 |
| Bologna, M; Festuccia, C; Gravina, GL; Muzi, P; Pomante, R; Ventura, L; Vessella, RL; Vicentini, C | 1 |
| Daw, HA; Kundranda, MN; Muslimani, A; Spiro, TP | 1 |
| Barbón, JJ; Gay, LL; González-Tuero, J; Pérez-García, FJ; Sampedro, A | 1 |
| Bradley, DA; Chenevert, TL; Galban, CJ; Hussain, M; Jacobson, JA; Johnson, TD; Lee, KC; Meyer, CR; Pienta, KJ; Rehemtulla, A; Ross, BD | 1 |
| Crawford, ED; Flaig, TW; Glodé, LM; Hussain, MH; Raghavan, D; Stadler, WM; Tangen, CM | 1 |
| Chapman, RA; Crawford, ED; Eisenberger, MA; Fontana, JA; Hussain, MH; Mills, GM; Parab, M; Raghavan, D; Sartor, AO; Tangen, CM | 1 |
| Ersoy, H; Gucuk, O; Han, U; Sagnak, L; Topaloglu, H | 1 |
| Abrahamsson, PA; Bjartell, AS; Dizeyi, N; Eide, T; Krobert, KA; Levy, FO; Ramberg, H; Taskén, KA | 1 |
| Block, N; Jones, J; Kolvenbag, G; Patterson, AL; Sarosdy, M; Schellhammer, P; Sharifi, R; Soloway, M; Venner, P; Vogelzang, N | 1 |
| Berrevoets, CA; Mulder, E; Veldscholte, J | 1 |
| Block, NL; Chen, Y; Kolvenbag, GJ; Patterson, AL; Sarosdy, MF; Schellhammer, PF; Sharifi, R; Soloway, MS; Venner, PM; Vogelzang, NJ | 1 |
| Chow, E; Dawson, LA; Morton, G | 1 |
| Esquenet, M; Goossens, K; Heyns, W; Swinnen, JV; Verhoeven, G | 1 |
| Hyytinen, E; Isola, J; Kallioniemi, OP; Koivisto, P; Palmberg, C; Tammela, T; Visakorpi, T | 1 |
| Akaza, H; Ideyama, Y; Onozawa, M; Shirai, T; Tsukamoto, S | 1 |
| Bono, AV; Diamanti, L; Galetti-Prayer, T; Montironi, R; Pagano, F; Santinelli, A; Selvaggi, FP; Zattoni, F | 1 |
| Block, NL; Kelley, RP; Kolvenbag, GJ; McLeod, DG; Patterson, AL; Sarosdy, MF; Schellhammer, PF; Sharifi, R; Soloway, MS; Venner, PM; Vogelzang, NJ | 1 |
| Biagini, G; Lucarini, G; Mazzucchelli, R; Montironi, R; Pugnaloni, A; Santinelli, A | 1 |
| Leibowitz, RL; Tucker, SJ | 1 |
| Hintz, BL; Kagan, AR; Van Nieuwenhuize, A | 1 |
| Chatta, GS; Coleman, D; Crawford, ED; Eisenberger, MA; Fisher, E; Hussain, MH; Kucuk, O; Lowe, BA; Moinpour, CM; Sartor, AO | 1 |
| Amin, P; Chen, T; Dawson, N; Engstrom, C; Hussain, A; Naslund, M | 1 |
8 review(s) available for bicalutamide and Adenocarcinoma
| Article | Year |
|---|---|
Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
Topics: Adenocarcinoma; Anastrozole; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Dizziness; Dose Fractionation, Radiation; Drug Administration Schedule; Estrogen Receptor Modulators; Flushing; Gynecomastia; Humans; Male; Mastodynia; Meta-Analysis as Topic; Neoplasms, Hormone-Dependent; Nitriles; Off-Label Use; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tamoxifen; Tosyl Compounds | 2020 |
[Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
Topics: Adenocarcinoma; Aged, 80 and over; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fatal Outcome; Humans; Leuprolide; Lower Urinary Tract Symptoms; Male; Nitriles; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds | 2017 |
Development of carcinoid tumour in hormonally treated adenocarcinoma of the prostate.
Topics: Adenocarcinoma; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Carcinoid Tumor; Humans; Liver Neoplasms; Male; Malignant Carcinoid Syndrome; Neoplasms, Multiple Primary; Nitriles; Positron-Emission Tomography; Prostatic Neoplasms; Somatostatin; Tosyl Compounds | 2009 |
Disseminated intravascular coagulation secondary to metastatic prostate cancer: case report and review of the literature.
Topics: Adenocarcinoma; Anilides; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diagnosis, Differential; Disseminated Intravascular Coagulation; Ecchymosis; Femur; Hematuria; Humans; Leuprolide; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2009 |
Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Diethylstilbestrol; Disease-Free Survival; Drug Administration Schedule; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Male; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Salvage Therapy; Tosyl Compounds; Treatment Outcome | 2003 |
Monotherapy in advanced prostate cancer: an overview.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Dihydrotestosterone; Estrogens; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Nitriles; Orchiectomy; Palliative Care; Progesterone Congeners; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Testosterone; Tosyl Compounds | 2004 |
Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus.
Topics: Adenocarcinoma; Adult; Aged; Anilides; Antineoplastic Agents, Hormonal; Antiretroviral Therapy, Highly Active; Biomarkers, Tumor; Brachytherapy; Case Management; Combined Modality Therapy; Cryosurgery; Finasteride; Follow-Up Studies; HIV Infections; Humans; Leuprolide; Life Expectancy; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy, High-Energy; Retrospective Studies; Tosyl Compounds | 2005 |
New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.
Topics: Adenocarcinoma; Adult; Androgen Antagonists; Anilides; Antineoplastic Agents; Cell Transformation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Neuroendocrine Tumors; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2006 |
24 trial(s) available for bicalutamide and Adenocarcinoma
| Article | Year |
|---|---|
Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Cohort Studies; Goserelin; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Male; Neoadjuvant Therapy; Nitriles; Obesity; Prostatectomy; Prostatic Neoplasms; Receptor, IGF Type 1; Risk; Secondary Prevention; Somatomedins; Tosyl Compounds; United States | 2013 |
Sunitinib plus androgen deprivation and radiation therapy for patients with localized high-risk prostate cancer: results from a multi-institutional phase 1 study.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Combined Modality Therapy; Drug Interactions; Feasibility Studies; Goserelin; Humans; Indoles; Leuprolide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nitriles; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrroles; Radiotherapy, Intensity-Modulated; Seminal Vesicles; Sunitinib; Tosyl Compounds | 2013 |
A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Humans; Kallikreins; Leuprolide; Male; Middle Aged; Neoplasm Grading; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Tosyl Compounds; Treatment Failure | 2013 |
Phase I trial of weekly docetaxel, total androgen blockade, and image-guided intensity-modulated radiotherapy for localized high-risk prostate adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Docetaxel; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nitriles; Prostatic Neoplasms; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Taxoids; Tosyl Compounds; Treatment Outcome | 2014 |
Significance of baseline bone markers on disease progression and survival in hormone-sensitive prostate cancer with bone metastasis.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alkaline Phosphatase; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Neoplasms; Diphosphonates; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Therapy, Combination; Follow-Up Studies; Goserelin; Humans; Imidazoles; Japan; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Tosyl Compounds; Zoledronic Acid | 2015 |
High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Chemoradiotherapy; Disease-Free Survival; Drug Administration Schedule; Flutamide; Gonadotropin-Releasing Hormone; Hospitals, University; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Nitriles; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Conformal; Risk Factors; Spain; Time Factors; Tosyl Compounds; Treatment Outcome | 2015 |
The effect of concurrent androgen deprivation and 3D conformal radiotherapy on prostate volume and clinical organ doses during treatment for prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Goserelin; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Prostatic Neoplasms; Radiation Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Rectum; Tomography, X-Ray Computed; Tosyl Compounds; Treatment Outcome; Urinary Bladder | 2009 |
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Dose Fractionation, Radiation; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Nitriles; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Conformal; Seminal Vesicles; Tosyl Compounds | 2010 |
Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.
Topics: Adenocarcinoma; Anilides; Antineoplastic Agents; Computer Simulation; Gene Expression Regulation, Neoplastic; Gene Fusion; Goserelin; Humans; In Situ Hybridization, Fluorescence; Male; MicroRNAs; Neoadjuvant Therapy; Nitriles; Oligonucleotide Array Sequence Analysis; Oncogene Proteins, Fusion; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds; Tumor Cells, Cultured | 2013 |
Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Receptor Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Everolimus; Humans; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Sirolimus; Tosyl Compounds; Treatment Outcome | 2012 |
Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: feasibility and toxicity.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Doxorubicin; Humans; Leuprolide; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Nitriles; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2003 |
Elevated E-cadherin and alpha/beta-catenin expression after androgen deprivation therapy in prostate adenocarcinoma.
Topics: Adenocarcinoma; alpha Catenin; Androgen Antagonists; Anilides; Antineoplastic Agents; beta Catenin; Cadherins; Cytoskeletal Proteins; Humans; Immunoenzyme Techniques; Male; Neoplasm Invasiveness; Nitriles; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds; Trans-Activators; Treatment Outcome | 2003 |
Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma.
Topics: Adenocarcinoma; Aged; Androgens; Anilides; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Cell Differentiation; Chromogranin A; Chromogranins; Disease Progression; Gonadotropin-Releasing Hormone; Humans; Lymph Node Excision; Male; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neurosecretory Systems; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds; Triptorelin Pamoate | 2004 |
Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer.
Topics: Adenocarcinoma; Age of Onset; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Breast; Follow-Up Studies; Gynecomastia; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Nitriles; Pain; Prostatic Neoplasms; Retrospective Studies; Tosyl Compounds; Treatment Outcome | 2005 |
Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Humans; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2006 |
Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Fatal Outcome; Goserelin; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Nitriles; Prednisone; Prostatectomy; Prostatic Neoplasms; Risk Assessment; Risk Factors; Southwestern United States; Survival Analysis; Tosyl Compounds | 2008 |
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Neoplasms; Disease-Free Survival; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Middle Aged; Nitriles; Orchiectomy; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Substance Withdrawal Syndrome; Survival Rate; Tosyl Compounds | 2008 |
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Double-Blind Method; Flutamide; Follow-Up Studies; Goserelin; Humans; Leuprolide; Male; Middle Aged; Nitriles; Proportional Hazards Models; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Regression Analysis; Survival Rate; Tosyl Compounds; Treatment Failure | 1995 |
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Double-Blind Method; Flutamide; Goserelin; Humans; Leuprolide; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 1996 |
Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer. Initial results of the Italian PROSIT study.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Goserelin; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Time Factors; Tosyl Compounds; Treatment Outcome | 1999 |
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Black People; Bone Neoplasms; Cohort Studies; Disease Progression; Disease-Free Survival; Double-Blind Method; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tosyl Compounds; White People | 1999 |
Treatment of localized prostate cancer with intermittent triple androgen blockade: preliminary results in 110 consecutive patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Finasteride; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2001 |
Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235).
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diethylstilbestrol; Disease Progression; Humans; Male; Middle Aged; Nitriles; Orchiectomy; Pain; Pain Measurement; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Tosyl Compounds; Treatment Outcome | 2001 |
Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: preliminary results.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Docetaxel; Finasteride; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Paclitaxel; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Salvage Therapy; Taxoids; Tosyl Compounds | 2001 |
84 other study(ies) available for bicalutamide and Adenocarcinoma
| Article | Year |
|---|---|
Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Chlormadinone Acetate; Flutamide; Humans; Male; Middle Aged; Nitriles; Patient Selection; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Survival Rate; Tosyl Compounds | 2020 |
An unusual case of "sterile" abscess within low-grade meningioma during anti androgenic therapy and LH-releasing hormone agonist treatment for prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Brain Abscess; Combined Modality Therapy; Craniotomy; Hearing Loss, Unilateral; Humans; Incidental Findings; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Necrosis; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Neuroimaging; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2020 |
Failure to achieve castrate level of serum testosterone during luteinizing hormone-releasing hormone agonist therapy in a patient with prostate cancer.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Gonadotropin-Releasing Hormone; Goserelin; Humans; Kallikreins; Leuprolide; Male; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Testosterone; Tosyl Compounds | 2020 |
The lncRNA PTTG3P promotes the progression of CRPC via upregulating PTTG1.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Animals; Antineoplastic Agents, Hormonal; Binding, Competitive; Cell Line, Tumor; Drug Resistance, Neoplasm; Heterografts; Humans; Male; Mice, Nude; MicroRNAs; Neoplasm Transplantation; Nitriles; Prostatic Neoplasms, Castration-Resistant; Pseudogenes; RNA, Long Noncoding; RNA, Messenger; RNA, Neoplasm; Securin; Tosyl Compounds; Tumor Stem Cell Assay; Up-Regulation | 2021 |
Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621.
Topics: Adenocarcinoma; Adult; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Gonadotropin-Releasing Hormone; Humans; Kallikreins; Male; Middle Aged; Multivariate Analysis; Neoplasm Grading; Neoplasm Staging; Nitriles; Proportional Hazards Models; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Taxoids; Tosyl Compounds | 2017 |
Cutaneous Metastases From Adenocarcinoma of the Prostate.
Topics: Adenocarcinoma; Aged, 80 and over; Anilides; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Fatal Outcome; Goserelin; Humans; Lymphatic Metastasis; Male; Nitriles; Prostatic Neoplasms; Skin Neoplasms; Skin Ulcer; Tosyl Compounds; Transurethral Resection of Prostate | 2018 |
Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient.
Topics: Adenocarcinoma; Aged, 80 and over; Alopecia; Anilides; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Fibrosis; Goserelin; Humans; Male; Nitriles; Prostatic Neoplasms; Scalp; Skin; Tosyl Compounds | 2018 |
Androgen receptor in salivary gland carcinoma: A review of an old marker as a possible new target.
Topics: Adenocarcinoma; Administration, Oral; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Female; Humans; Male; Molecular Targeted Therapy; Nitriles; Phenylthiohydantoin; Receptors, Androgen; Salivary Ducts; Salivary Gland Neoplasms; Tosyl Compounds | 2018 |
A Case of Metastatic Prostate Cancer to the Urethra That Resolved After Androgen Deprivation Therapy.
Topics: Adenocarcinoma; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Humans; Leuprolide; Male; Nitriles; Prostatic Neoplasms; Remission Induction; Tosyl Compounds; Urethral Neoplasms | 2019 |
The successful treatment of metastatic androgen receptor-positive tumours of parotid origin with androgen receptor blockade and immunotherapy.
Topics: Adenocarcinoma; Adult; Aged; Androgen Receptor Antagonists; Androstenes; Anilides; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bone Neoplasms; Cancer Vaccines; Humans; Male; Nitriles; Parotid Neoplasms; Receptors, Androgen; Tosyl Compounds | 2019 |
Prostate cancer risk after anti-androgen treatment for priapism.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Delayed Diagnosis; Humans; Male; Nitriles; Phosphodiesterase 5 Inhibitors; Piperazines; Priapism; Prostate-Specific Antigen; Prostatic Neoplasms; Purines; Secondary Prevention; Sildenafil Citrate; Sulfones; Tosyl Compounds | 2014 |
Progression of intracranial meningioma during luteinizing hormone-releasing hormone agonist treatment for prostate cancer: case report.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Gastrectomy; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Nitriles; Prostatectomy; Prostatic Neoplasms; Receptors, LH; Stomach Neoplasms; Tosyl Compounds | 2014 |
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.
Topics: Adenocarcinoma; Adult; Androgen Antagonists; Androstenes; Androstenols; Anilides; Antineoplastic Agents, Hormonal; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Androgen; Salivary Gland Neoplasms; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate | 2014 |
Metastatic castrate-resistant prostate cancer with a late, complete and durable response to docetaxel chemotherapy: a case report.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Docetaxel; Goserelin; Humans; Lymphatic Metastasis; Male; Nitriles; Prostate; Prostatic Neoplasms; Taxoids; Tosyl Compounds; Treatment Failure; Treatment Outcome | 2014 |
Lack of energy, petechiae, elevated PSA level--Dx?
Topics: Adenocarcinoma; Anilides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bone Neoplasms; Diagnosis, Differential; Fatigue; Glucocorticoids; Humans; Leuprolide; Male; Middle Aged; Nitriles; Plasma Exchange; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Purpura; Purpura, Thrombotic Thrombocytopenic; Thoracic Vertebrae; Tomography, X-Ray Computed; Tosyl Compounds; Treatment Outcome | 2014 |
Prostatic adenocarcinoma presenting as isolated inguinal lymphadenopathy.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents; Humans; Lymphatic Diseases; Lymphatic Metastasis; Male; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Tomography, X-Ray Computed; Tosyl Compounds; Treatment Outcome | 2015 |
Male Malignant Phyllodes Breast Tumor After Prophylactic Breast Radiotherapy and Bicalutamide Treatment: A Case Report.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents; Breast Neoplasms, Male; Humans; Male; Nitriles; Phyllodes Tumor; Prostatic Neoplasms; Radiotherapy, Adjuvant; Tosyl Compounds | 2016 |
[Fatal interstitial lung disease associated with maximum androgen blockade].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antinematodal Agents; Biopsy; Disease Progression; Fatal Outcome; Humans; Lung Diseases, Interstitial; Male; Nitriles; Prostatic Neoplasms; Tomography, X-Ray Computed; Tosyl Compounds | 2016 |
Androgen deprivation in prostate cancer and the long-term risk of fracture.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Calcium; Combined Modality Therapy; Femur Neck; Follow-Up Studies; Fractures, Spontaneous; Gonadotropin-Releasing Hormone; Humans; Interviews as Topic; Lumbar Vertebrae; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Osteoporosis; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Software; Tosyl Compounds; Vitamin D | 2017 |
Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
Topics: Adenocarcinoma; Aged, 80 and over; Androgen Antagonists; Androgens; Anilides; Biopsy, Fine-Needle; Diagnosis, Differential; Histological Techniques; Humans; Male; Nitriles; Orchiectomy; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2008 |
Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Androgens; Anilides; Buserelin; Diarrhea; Flutamide; Gastrectomy; Glaucoma; Gonadotropin-Releasing Hormone; Hernia, Hiatal; Humans; Luteinizing Hormone; Male; Nitriles; Peptic Ulcer; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2009 |
Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation.
Topics: Adenocarcinoma; Androgens; Anilides; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Dose-Response Relationship, Radiation; Fibronectins; Humans; Integrins; Male; Nitriles; Prostatic Neoplasms; Radiation, Ionizing; Tosyl Compounds | 2008 |
Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
Topics: Adenocarcinoma; Androgens; Anilides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chromatin; DNA, Neoplasm; Histone Acetyltransferases; Humans; Male; Nitriles; Nuclear Receptor Coactivator 1; Nuclear Receptor Coactivator 2; Oligonucleotide Array Sequence Analysis; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Binding; Receptors, Androgen; rho-Associated Kinases; Tosyl Compounds; Transcription Factors | 2008 |
A dramatic, objective antiandrogen withdrawal response: case report and review of the literature.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2008 |
Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer.
Topics: Adenocarcinoma; Anilides; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Basidiomycota; Combined Modality Therapy; Drug Resistance, Neoplasm; Humans; Leuprolide; Lumbar Vertebrae; Male; Nitriles; Phytotherapy; Plant Extracts; Polysaccharides; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Remission Induction; Samarium; Self Medication; Spinal Neoplasms; Tosyl Compounds | 2009 |
Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.
Topics: Adenocarcinoma; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Animals; Apoptosis; Bucladesine; Cell Division; Colforsin; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Enzyme Induction; Gene Knockdown Techniques; Humans; Isoquinolines; Male; Metribolone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Neoplasms; Receptors, Androgen; RNA, Small Interfering; Signal Transduction; Sulfonamides; Tosyl Compounds | 2010 |
Antagonistic interaction between bicalutamide (Casodex) and radiation in androgen-positive prostate cancer LNCaP cells.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; G1 Phase; Humans; Male; Neoadjuvant Therapy; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Adjuvant; Receptors, Androgen; S Phase; Time Factors; Tosyl Compounds | 2010 |
Metastatic prostatic adenocarcinoma mimicking inflammatory breast carcinoma: a case report.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Capecitabine; Carotid Stenosis; Coronary Artery Disease; Cyclophosphamide; Deoxycytidine; Diabetes Mellitus; Fluorouracil; Humans; Immunohistochemistry; Leuprolide; Male; Nitriles; Osteoarthritis; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Tomography, X-Ray Computed; Tosyl Compounds | 2010 |
Long-term survival and PSA control with radiation and immunotherapy for node positive prostate cancer.
Topics: Adenocarcinoma; Anilides; Antineoplastic Agents, Hormonal; B7-1 Antigen; Cancer Vaccines; Goserelin; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Engineering; Radiography, Abdominal; Radiotherapy; T-Lymphocytes; Tosyl Compounds; Ultrasound, High-Intensity Focused, Transrectal; Vaccines, Synthetic | 2009 |
Salvage therapy with bicalutamide 150 mg in nonmetastatic castration-resistant prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Castration; Gonadotropin-Releasing Hormone; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Salvage Therapy; Survival Rate; Tosyl Compounds | 2010 |
[Results of 125-iodine seed implant with preplanning system in 250 patients with prostate cancer].
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Brachytherapy; Combined Modality Therapy; Computer Systems; Humans; Iodine Radioisotopes; Male; Middle Aged; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Radiography, Interventional; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tosyl Compounds; Treatment Outcome | 2011 |
Prostate adenocarcinoma with orbital metastasis in an HIV+ man.
Topics: Adenocarcinoma; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; HIV Seropositivity; Humans; Immunocompromised Host; Leuprolide; Male; Middle Aged; Nitriles; Orbital Neoplasms; Palliative Care; Prostatic Neoplasms; Radiotherapy, Intensity-Modulated; Tosyl Compounds | 2011 |
[Disseminated carcinomatosis of the bone marrow in two patients with prostate cancer].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Bone Marrow Neoplasms; Carcinoma; Diphosphonates; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Fatal Outcome; Humans; Imidazoles; Leuprolide; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome; Zoledronic Acid | 2011 |
Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
Topics: Adenocarcinoma; Androgen Receptor Antagonists; Anilides; Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Homeodomain Proteins; Humans; Male; Nitriles; Plant Extracts; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Signal Transduction; Tosyl Compounds; Transcription Factors | 2012 |
Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Animals; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Drug Implants; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Male; Metribolone; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Nitriles; Orchiectomy; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Receptors, Androgen; S-Phase Kinase-Associated Proteins; Testosterone; Tosyl Compounds; Xenograft Model Antitumor Assays | 2011 |
Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.
Topics: Adenocarcinoma; Anilides; Animals; Antineoplastic Agents; Apoptosis; Carbidopa; Cell Line, Tumor; Cell Survival; Disease Progression; Dopamine Agents; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Male; Mice; Mice, Nude; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; Treatment Outcome; Xenograft Model Antitumor Assays | 2012 |
[Impact of androgen deprivation on the lipid profile and atherogenic risk in prostate cancer patients].
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Atherosclerosis; Biopsy; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Gonadotropin-Releasing Hormone; Humans; Lipoproteins; Male; Nitriles; Prostate; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Risk; Tosyl Compounds; Triglycerides; Triptorelin Pamoate | 2012 |
[Prostate carcinoma with squamous differentiation after combination endocrine therapy: a case report].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Goserelin; Humans; Lymph Node Excision; Male; Nitriles; Prostatectomy; Prostatic Neoplasms; Taxoids; Tosyl Compounds | 2012 |
[Osteosarcoma of the prostate after radiotherapy].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Combined Modality Therapy; Disease Progression; Fatal Outcome; Goserelin; Humans; Male; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Nitriles; Prostatic Neoplasms; Tosyl Compounds; Transurethral Resection of Prostate | 2012 |
Complete biochemical (prostate-specific antigen) response to sipuleucel-T with enzalutamide in castration-resistant prostate cancer: a case report with implications for future research.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Cancer Vaccines; Gonadotropin-Releasing Hormone; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tissue Extracts; Tosyl Compounds; Treatment Outcome | 2013 |
Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after prostate brachytherapy.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Brachytherapy; Chemotherapy, Adjuvant; Diarrhea; Enzyme Inhibitors; Finasteride; Flutamide; Humans; Logistic Models; Male; Nitriles; Penile Erection; Prostatic Neoplasms; Quality of Life; Tosyl Compounds; Treatment Outcome; Urinary Incontinence | 2003 |
Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
Topics: Absorptiometry, Photon; Adenocarcinoma; Aged; Amino Acids; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Remodeling; Calcium; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Osteoporosis; Prospective Studies; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2002 |
Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Animals; Anticarcinogenic Agents; Binding, Competitive; Cell Division; Cell Nucleus; Cytoplasm; Dihydrotestosterone; DNA; Gene Expression Regulation, Neoplastic; Indoles; Male; Metribolone; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Signal Transduction; Testosterone Congeners; Tosyl Compounds; Transcription, Genetic; Tumor Cells, Cultured; Vegetables | 2003 |
[A case of locally advanced prostate cancer with low serum testosterone associated with intake of an androgenic medicine].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Gonadotropin-Releasing Hormone; Humans; Male; Methyltestosterone; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2003 |
A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Nitriles; Parotid Gland; Parotid Neoplasms; Radiotherapy, Adjuvant; Receptors, Androgen; Risk Assessment; Skin Ulcer; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate | 2003 |
Impact of hormone therapy when combined with external beam radiotherapy for early-stage, intermediate-, or high-risk prostate cancer.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Flutamide; Goserelin; Humans; Male; Neoadjuvant Therapy; Nitriles; Prostatic Neoplasms; Survival Analysis; Tosyl Compounds | 2003 |
Antiandrogenic activities of diesel exhaust particle extracts in PC3/AR human prostate carcinoma cells.
Topics: Adenocarcinoma; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Benzoflavones; beta-Galactosidase; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Dihydrotestosterone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Luciferases; Male; Nitriles; Polycyclic Aromatic Hydrocarbons; Proadifen; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Receptors, Aryl Hydrocarbon; Saccharomyces cerevisiae; Tosyl Compounds; Vehicle Emissions | 2003 |
[A case of seminal vesicle cyst due to the obstruction of the ejaculatory duct: possible association with prostate cancer].
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cysts; Diagnostic Imaging; Ejaculatory Ducts; Genital Diseases, Male; Goserelin; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Seminal Vesicles; Tosyl Compounds | 2004 |
Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Erectile Dysfunction; Finasteride; Humans; Male; Middle Aged; Neoplasm Staging; Nitriles; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2004 |
Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen.
Topics: Adenocarcinoma; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Goserelin; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasms, Second Primary; Neutropenia; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostate-Specific Antigen; Prostatic Neoplasms; Recurrence; Sepsis; Tosyl Compounds; Vincristine | 2004 |
A case of male breast cancer in association with bicalutamide-induced gynaecomastia.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Breast Neoplasms, Male; Gynecomastia; Humans; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2005 |
Successful recovery from interstitial pneumonitis, induced by bicalutamide and leuprorelin acetate given as treatment for prostate cancer.
Topics: Adenocarcinoma; Aged; Anilides; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; Humans; Leuprolide; Lung Diseases, Interstitial; Male; Methylprednisolone Hemisuccinate; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2005 |
Case study: management of advanced prostate cancer with soft tissue metastases.
Topics: Adenocarcinoma; Anilides; Disease Progression; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quality of Life; Risk; Soft Tissue Neoplasms; Time Factors; Tomography, X-Ray Computed; Tosyl Compounds; Treatment Outcome | 2005 |
Case study: management of lymph node-positive disease detected at radical prostatectomy.
Topics: Adenocarcinoma; Aged; Anilides; Biopsy; Disease Progression; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Prunus; Quality of Life; Tosyl Compounds; Vitamin B Complex | 2005 |
Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer.
Topics: Adenocarcinoma; Age Factors; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Disease Progression; Disease-Free Survival; Follow-Up Studies; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Nitriles; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Tosyl Compounds; Treatment Failure | 2005 |
Insulin resistance as an adverse effect of leuprolide and bicalutamide treatment.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Humans; Insulin Resistance; Leuprolide; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 2005 |
[A case of prostatic cancer discovered from lung metastatic lesions].
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Humans; Leuprolide; Lung Neoplasms; Male; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tomography, X-Ray Computed; Tosyl Compounds | 2006 |
Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
Topics: Abscess; Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Bone Neoplasms; Delayed-Action Preparations; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds; Treatment Failure | 2006 |
Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Disease Progression; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Nitriles; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Tosyl Compounds; Triptorelin Pamoate | 2006 |
Hot flashes.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Arrhythmias, Cardiac; Evidence-Based Medicine; Hot Flashes; Humans; Male; Nitriles; Nursing Assessment; Patient Care Planning; Prostatic Neoplasms; Sweating; Tosyl Compounds | 2006 |
Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Biomarkers, Tumor; Bone Neoplasms; Disease-Free Survival; Follow-Up Studies; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Nitriles; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Receptor, ErbB-2; Retrospective Studies; Survival Rate; Tosyl Compounds; Treatment Outcome | 2006 |
Ligand-specific dynamics of the androgen receptor at its response element in living cells.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Animals; Cell Line, Tumor; Chromatin Assembly and Disassembly; Cyproterone Acetate; Dihydrotestosterone; Female; Fluorescence Recovery After Photobleaching; Flutamide; Genes, Reporter; Green Fluorescent Proteins; In Situ Hybridization, Fluorescence; Ligands; Luciferases; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Metribolone; Mice; Microscopy, Video; Mifepristone; Models, Biological; Nitriles; Plasmids; Promoter Regions, Genetic; Receptors, Androgen; Response Elements; Testosterone; Tosyl Compounds; Transcription, Genetic | 2007 |
[Giant prostate carcinoma treated effectively with endocrine therapy: case report].
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Chlormadinone Acetate; Drug Administration Schedule; Drug Therapy, Combination; Goserelin; Humans; Magnetic Resonance Imaging; Male; Naphthalenes; Nitriles; Piperazines; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2007 |
Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Drug Therapy, Combination; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Neoplasm Staging; Nitriles; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome | 2007 |
Prostate cancer tissue is masked by bicalutamide: a case report.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Biopsy, Needle; Humans; Immunohistochemistry; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nitriles; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tosyl Compounds | 2007 |
Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Aspartate Aminotransferase, Mitochondrial; Blotting, Western; Cell Line, Tumor; Fatty Acid-Binding Proteins; Fatty Acids; Flow Cytometry; Humans; Male; Metribolone; Microscopy, Confocal; Neoplasms, Hormone-Dependent; Nitriles; Oleic Acid; Prostatic Neoplasms; Tosyl Compounds; Up-Regulation | 2007 |
Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Choice Behavior; Cross-Sectional Studies; Diarrhea; Drug Administration Schedule; Drug Costs; Drug Therapy; Erectile Dysfunction; Flutamide; Gynecomastia; Health Surveys; Hematuria; Humans; Life Expectancy; Male; Middle Aged; Nitriles; Patient Acceptance of Health Care; Patient Satisfaction; Prostatic Neoplasms; Tosyl Compounds | 2008 |
Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Docetaxel; Estramustine; Etoposide; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Nephrostomy, Percutaneous; Nitriles; Phenotype; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Tosyl Compounds; Transurethral Resection of Prostate; Urinary Diversion | 2007 |
Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Cell Differentiation; Goserelin; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds | 2007 |
Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Nitriles; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Risk; Survival Analysis; Testosterone; Tosyl Compounds | 2007 |
[Solitary peritoneal carcinomatosis in prostate cancer].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Follow-Up Studies; Goserelin; Humans; Lymph Node Excision; Male; Nitriles; Peritoneal Neoplasms; Peritoneum; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Tosyl Compounds; Transurethral Resection of Prostate; Treatment Outcome | 2007 |
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer.
Topics: Adenocarcinoma; Aged; Anilides; Animals; Antineoplastic Agents; ErbB Receptors; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoadjuvant Therapy; Neoplasms, Hormone-Dependent; Nitriles; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptor, ErbB-2; Retrospective Studies; Tosyl Compounds; Xenograft Model Antitumor Assays | 2007 |
Complete remission of metastatic carcinoma of the prostate with bicalutamide withdrawal.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Retrospective Studies; Tosyl Compounds | 2007 |
[Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy].
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Bone Neoplasms; Choroid Neoplasms; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Nitriles; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Tosyl Compounds; Treatment Outcome | 2007 |
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone.
Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Body Water; Bone Neoplasms; Cell Membrane Permeability; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Goserelin; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Tomography, X-Ray Computed; Tosyl Compounds; Treatment Outcome; Whole Body Imaging | 2007 |
Skip metastase on the left neck lymph nodes of the prostatic adenocarcinoma with neuroendocrine differentiation and accompanying thyroid micropapillary carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Androgen Antagonists; Anilides; Cell Differentiation; Humans; Incidental Findings; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Multiple Primary; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Thyroid Neoplasms; Thyroidectomy; Tosyl Compounds; Whole Body Imaging | 2008 |
Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents; Biopsy; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Nitriles; Oligonucleotide Array Sequence Analysis; Prostate; Prostatic Neoplasms; Receptors, Adrenergic, beta-2; Receptors, Androgen; Signal Transduction; Tosyl Compounds; Triiodothyronine; Up-Regulation | 2008 |
Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
Topics: Adenocarcinoma; Alanine; Amino Acid Sequence; Androgen Antagonists; Anilides; Animals; Blotting, Western; Cell Line; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Cyproterone Acetate; Dose-Response Relationship, Drug; Flutamide; Humans; Male; Metribolone; Mutagenesis, Site-Directed; Nitriles; Point Mutation; Prostatic Neoplasms; Receptors, Androgen; Recombinant Proteins; Threonine; Tosyl Compounds; Transcription, Genetic; Transfection; Transformation, Genetic; Tumor Cells, Cultured | 1993 |
Fulminant hepatic failure associated with bicalutamide.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Hepatic Encephalopathy; Humans; Male; Middle Aged; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 1997 |
Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Dihydrotestosterone; Dose-Response Relationship, Drug; Enzyme Induction; Fatty Acid Synthases; Gene Expression Regulation, Neoplastic; Humans; Lipids; Male; Metribolone; Nandrolone; Neoplasm Proteins; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Testosterone Congeners; Tosyl Compounds; Tumor Cells, Cultured | 1997 |
Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.
Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Biomarkers, Tumor; DNA, Neoplasm; Endosonography; Follow-Up Studies; Gene Amplification; Humans; In Situ Hybridization, Fluorescence; Male; Neoplasm Recurrence, Local; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds | 1997 |
A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adenocarcinoma; Aminobiphenyl Compounds; Androgen Antagonists; Anilides; Animals; Carcinogens; Disease Progression; Enzyme Inhibitors; Finasteride; Male; Nitriles; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone; Tosyl Compounds | 1998 |
Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Endothelial Growth Factors; Goserelin; Humans; Immunohistochemistry; Lymphokines; Male; Middle Aged; Neovascularization, Pathologic; Nitriles; Prostatectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Tosyl Compounds; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Prostate-specific antigen-all that rises is not refractory.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Delayed-Action Preparations; Humans; Injections, Intramuscular; Leuprolide; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds; Treatment Outcome | 2001 |